The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,710.00
Bid: 5,700.00
Ask: 5,705.00
Change: 40.00 (0.71%)
Spread: 5.00 (0.088%)
Open: 5,615.00
High: 5,715.00
Low: 5,605.00
Prev. Close: 5,670.00
DCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

5 Feb 2019 07:00

RNS Number : 0414P
DCC PLC
05 February 2019
 

 

 

5 February 2019

 

DCC plc

 

Interim Management Statement

 

Trading in line with expectations

 

DCC plc, the leading international sales, marketing and support services group, is issuing this Interim Management Statement for the third quarter ended 31 December 2018.

 

Third quarter ended 31 December 2018

Group operating profit for the third quarter ended 31 December 2018 was significantly ahead of the prior year and in line with expectations, notwithstanding the milder winter weather conditions.

 

DCC LPG recorded strong operating profit growth. The business benefited from the first-time contribution from the prior year acquisitions of Retail West, TEGA and Shell Hong Kong & Macau, which continued to perform in line with expectations. Organically, the business performed well, despite the mild winter weather conditions experienced in the quarter, which impacted heating related volumes in Europe.

 

DCC Retail & Oil delivered strong organic operating profit growth, driven by good performances from the businesses in Britain and Denmark, despite the milder weather, and a robust performance in France where the business was impacted by the regular nationwide protests.

Operating profit in DCC Healthcare was well ahead of the prior year. DCC Vital generated strong organic profit growth and continued to strengthen its market position in GP supplies and medical devices in Britain. DCC Health & Beauty Solutions again delivered good organic growth in both nutrition and beauty and benefited from the first-time contribution from Elite One Source, which was acquired in the prior year.

 

DCC Technology recorded strong operating profit growth, driven by the first-time contribution from acquisitions and a good organic performance in the UK and Ireland. Jam and Stampede, DCC Technology's recent North American acquisitions, have been integrated into the Group and are performing well.

 

Year ending 31 March 2019

Notwithstanding the milder winter weather conditions, DCC expects that operating profit will be significantly ahead of the prior year and will be in line with current market consensus expectations.

 

Development activity

The Group's market leading positions, combined with the recent significant development activity and its strong and liquid balance sheet, provide DCC with the platforms, opportunities and capabilities to build the Group into a global leader in its chosen sectors.

 

Final results

DCC expects to announce its results for the year ending 31 March 2019 on 14 May 2019.

 

 

For reference:

Donal Murphy, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Capital Markets

 

Telephone: +353 1 2799400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

Powerscourt (Media)

Lisa Kavanagh / Victoria Palmer-Moore

 

Telephone: +44 20 7250 1446

Email: DCC@powerscourtgroup.com

 

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology.

 

DCC is an ambitious and entrepreneurial business operating in 17 countries, supplying products and services used by millions of people every day. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

 

Headquartered in Dublin, employing over 12,000 people, DCC's four divisions are:

· DCC LPG - a leading LPG sales and marketing business with operations in Europe, the USA and Asia and a developing business in the retailing of natural gas and electricity;

· DCC Retail & Oil - a leader in the sales, marketing and retailing of transport and commercial fuels, heating oils and related products and services in Europe;

· DCC Healthcare - a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners; and

· DCC Technology - a leading sales, marketing and value-added services partner for global technology brands.

 

DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2018, DCC generated revenue of £14.3 billion and operating profit of £383.4 million.

 

DCC has an excellent record, delivering compound annual growth of 14% in operating profit and generating an average return on capital employed of approximately 19% over 24 years as a public company.

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVZLFBKLFLBBK
Date   Source Headline
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1
25th Sep 20195:39 pmRNSHolding in Company TR-1
4th Sep 20199:57 amRNSHolding in Company TR-1
9th Aug 201910:42 amRNSHolding in Company TR-1
7th Aug 20199:23 amRNSHolding in Company TR-1
31st Jul 20192:58 pmRNSTotal Voting Rights
16th Jul 20196:14 pmRNSDirector/PDMR Shareholding
12th Jul 20193:06 pmRNSResult of AGM
12th Jul 20197:00 amRNSInterim Management Statement
5th Jul 20199:06 amRNSHolding in Company TR-1
19th Jun 20199:22 amRNSHolding in Company TR-1
13th Jun 201911:37 amRNS2019 Annual Report, Notice of AGM and Proxy Form
31st May 20199:47 amRNSTotal Voting Rights
28th May 20197:00 amRNSHolding in Company TR-1
23rd May 20196:25 pmRNSDirector/PDMR Shareholding
22nd May 20199:43 amRNSHolding in Company TR-1
16th May 20199:03 amRNSHolding in Company TR-1
14th May 20197:01 amRNSDCC Development Update
14th May 20197:00 amRNSResults for the year ended 31 March 2019
13th May 201910:14 amRNSBoard Change
28th Mar 20198:47 amRNSDirector Declaration
28th Feb 20199:00 amRNSTotal Voting Rights
5th Feb 20197:00 amRNSInterim Management Statement
1st Feb 20194:25 pmRNSHolding in Company TR-1
25th Jan 20193:12 pmRNSHolding in Company TR-1
22nd Jan 20192:27 pmRNSHolding in Company TR-1
10th Jan 201912:58 pmRNSHolding in Company TR-1
2nd Jan 20193:07 pmRNSHolding in Company TR-1
14th Dec 201811:50 amRNSHolding in Company TR-1
12th Dec 20189:08 amRNSHolding in Company TR-1
30th Nov 20183:03 pmRNSTotal Voting Rights
29th Nov 20184:50 pmRNSHolding in Company TR-1
19th Nov 20186:01 pmRNSHolding in Company TR-1
19th Nov 20185:59 pmRNSDirector/PDMR Shareholding
19th Nov 20182:27 pmRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
6th Nov 20185:45 pmRNSHolding in Company TR-1
31st Oct 20183:26 pmRNSTotal Voting Rights
30th Oct 20189:51 amRNSBoard Resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.